Altimmune to present at upcoming virtual investor conferences

Gaithersburg, md., nov. 16, 2020 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company advancing proprietary intranasal vaccines and peptide therapeutics for liver disease, today announced that management will present at the following upcoming virtual investor conferences:
ALT Ratings Summary
ALT Quant Ranking